Are you in touch with the latest payer thinking?

In the third of her five-part series on digital transformation in market access, Dr. Patti Peeples, CEO of HealthEconomics.com, sits down with Anja Pownell, Associate Director at PRMA Consulting, to find out how technology is putting dynamic payer thinking at the… Continue Reading

Pharmacy benefit managers: a mechanism for containing costs or a contributor to rising drug prices?

While pharmaceutical companies are often the focus of conversations about high drug prices, more recently pharmacy benefit managers (PBMs) have come under increased drug price scrutiny. The American PBM business model, developed in the early 2000s, was designed to identify… Continue Reading

Pricing a New Way for Services! Going Live Tonight!

Pricing methodologies in the healthcare industry are replete with critics, so-called “experts”, occasional wins, and myriad failed approaches.  In fact, we typically have to price a product before we fully understand its value to the marketplace.  This leads to mis-pricing, rebates, bundles, crazy price increases… Continue Reading

Drug Pricing Value Assessment Methods in the United States: The National Pharmaceutical Council Viewpoint

Written by Swarali Tadwalkar, MPH, Guest Blogger and Research Intern at HealthEconomics.Com Drug prices are the fastest-growing part of healthcare costs, and everyone – from patients, to physicians, policy-makers, and pharmaceutical companies – are grappling with price-setting and drug value assessment.… Continue Reading

Playing in the Real World Evidence Sandbox: Sharing, Teamwork, and Transparency

Is just playing in the same sandbox together an example of Real World Evidence (RWE) collaboration? Not really. So how exactly do you play nicely in the RWE ‘sandbox’, but really collaborate and actually get a project off the ground,… Continue Reading